QualityStocksNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) Announces AGM 2020 Results, Election of New Director
VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) on Thursday announced the election of each of the seven individuals nominated as a director of VIVO at the company’s Annual General and Special Meeting of Shareholders held on May 28, 2020. According to the update, VIVO management nominated each of the existing directors, together with new nominee, Christie Henderson, for election at the meeting. Henderson is the managing partner and CEO of Henderson Partners LLP, a firm of chartered professional accountants and advisors, as well as a certified corporate director (“ICD.D”). She has more than 20 years of experience with consumer products, retail, real estate, brewery, food and professional service industries and private equity, is an experienced board chair, and has served on various governance, audit and risk committees. “Christie is an outstanding addition to the Board and will bolster our commitment to being an industry leader in corporate governance,” VIVO’s CEO Barry Fishman said in the news release. “Having the counsel of one of Canada’s top female entrepreneurs is a tremendous asset and we look forward to benefiting from her expertise in a variety of areas, including financial and enterprise risk management as well as corporate strategy and performance.”
VIVO Cannabis(TM) is recognized for trusted, premium cannabis products and services. It holds production and sales licenses from Health Canada and operates world-class indoor and seasonal airhouse cultivation facilities with proprietary plant-growing technology in Hope, British Columbia and Napanee, Ontario. VIVO has a collection of premium brands, each targeting different customer segments, including Canna Farms(TM), Beacon Medical(TM), Fireside(TM), Lumina(TM) and Canadian Bud Collection(TM). The Company is expanding its production capabilities and distribution network. Harvest Medicine, VIVO’s patient-centric, scalable network of medical cannabis clinics, has serviced over 100,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia. The company has a healthy balance sheet and is well-positioned to accelerate its path to profitability. For more information, visit www.VIVOCannabis.com.
NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://ibn.fm/VVCIF
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.